Chat with us
Research Assistance
Online
  • Please enter your first name.

Latin America Metagenomics Market Size & Outlook, 2024-2030

The metagenomics market in Latin America is expected to reach a projected revenue of US$ 416.5 million by 2030. A compound annual growth rate of 13.9% is expected of Latin America metagenomics market from 2024 to 2030.

  • Biotechnology
    • Genomics & Genetic Engineering
      • Metagenomics Market Outlook
Revenue, 2023 (US$M)
$167.1
Forecast, 2030 (US$M)
$416.5
CAGR, 2024 - 2030
13.9%
Report Coverage
Latin America
GVR research-powered AI

Ask Prism AI about the metagenomics market

Get cited answers from GVR research on market growth, segments, regulations and forecasts.

  • Source-linked answers
  • Market-specific context
  • Traceable figures
Explore Prism AI

Latin America metagenomics market highlights

  • The Latin America metagenomics market generated a revenue of USD 167.1 million in 2023.
  • The market is expected to grow at a CAGR of 13.9% from 2024 to 2030.
  • In terms of segment, kits & reagents was the largest revenue generating product in 2023.
  • Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Brazil is expected to register the highest CAGR from 2024 to 2030.


Latin America data book summary

Market revenue in 2023USD 167.1 million
Market revenue in 2030USD 416.5 million
Growth rate13.9% (CAGR from 2023 to 2030)
Largest segmentKits & reagents
Fastest growing segmentSequencing & Data Analytics Services
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationKits & Reagents, Sequencing & Data Analytics Services, Software
Key market players worldwideBio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG


Other key industry trends

  • In terms of revenue, Latin America region accounted for 8.2% of the global metagenomics market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 938.3 million by 2030.

The Brazil metagenomics market is expected to continue R&D of molecular test kits using NGS to diagnose brain disorders such as autism through startup companies such as Mendelics and Genius.

Furthermore, the presence of a naturally diverse ethnic demographic in the region is expected to boost R&D for NGS-derived diagnostic kits and therapies for certain rare diseases. These potential avenues for further development of NGS applications are expected to fuel the market growth in this region during the forecast period.

The improving infrastructure, expanding sequencing technologies, and increasing interest of global players in this country are also driving the market. For instance, in November 2019, Veritas Intercontinental signed an agreement with genetic testing lab Genomika, based in Brazil, to offer whole-genome and exome sequencing services in this region.

No credit card required*

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study
Turnaround
5–10 working days

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Metagenomics Market Companies

NameProfile# EmployeesHQWebsite
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Roche Holding AGView profile 103,605Grenzacherstrasse 124, Basel, Switzerland, 4070www.roche.com
Illumina IncView profile 9,3005200 Illumina Way, San Diego, CA, United States, 92122www.illumina.com
Bio-Rad Laboratories IncView profile 8,0301000 Alfred Nobel Drive, Hercules, CA, United States, 94547www.bio-rad.com
Qiagen NVView profile 5,900Hulsterweg 82, Venlo, LI, Netherlands, 5912 PLwww.qiagen.com
Takara Bio IncView profile 1,793Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058www.takara-bio.co.jp
PerkinElmerView profile 10001+Waltham, Massachusetts, United States, North Americawww.perkinelmer.com
NovogeneView profile 501-1000Beijing, Beijing, China, Asiaen.novogene.com/
PromegaView profile 5001-10000Madison, Wisconsin, United States, North Americawww.promega.com/es
Oxford Nanopore Technologies PLCView profile 1,133Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, United Kingdom, OX4 4DQwww.nanoporetech.com

Latin America Metagenomics Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Metagenomics Market Outlook will help companies and investors design strategic landscapes.


Kits & Reagents was the largest segment with a revenue share of 61.46% in 2023.

Horizon Databook has segmented the Latin America metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.




The Brazil metagenomics market is expected to continue R&D of molecular test kits using NGS to diagnose brain disorders such as autism through startup companies such as Mendelics and Genius.

Furthermore, the presence of a naturally diverse ethnic demographic in the region is expected to boost R&D for NGS-derived diagnostic kits and therapies for certain rare diseases. These potential avenues for further development of NGS applications are expected to fuel the market growth in this region during the forecast period.

The improving infrastructure, expanding sequencing technologies, and increasing interest of global players in this country are also driving the market. For instance, in November 2019, Veritas Intercontinental signed an agreement with genetic testing lab Genomika, based in Brazil, to offer whole-genome and exome sequencing services in this region.

  • Latin America Metagenomics Market Application Outlook (Revenue, USD Million , 2018-2030)
    • Others
    • Clinical Diagnostics
    • Drug Discovery
    • Biotechnology
    • Environmental
    • Food & nutrition
  • Latin America Metagenomics Market Technology Outlook (Revenue, USD Million , 2018-2030)
    • Whole Genome Sequencing
    • Shotgun Sequencing
    • Others
    • 16S Sequencing
  • Latin America Metagenomics Market Product Outlook (Revenue, USD Million , 2018-2030)
    • Sequencing & Data Analytics Services
    • Kits & Reagents
    • Software
  • Latin America Metagenomics Market Workflow Outlook (Revenue, USD Million , 2018-2030)
    • Pre-sequencing
    • Sequencing
    • Data Analysis

Reasons to subscribe to Metagenomics Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Metagenomics Market Outlook databook

  • Our clientele includes a mix of Metagenomics Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America Metagenomics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Latin America Metagenomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Latin America Metagenomics Market, 2018-2030 (US$M)

No Access Stack Chart

Latin America metagenomics market statistics, by application, 2018-2030 (US$M)

No Access Pie Chart

Latin America metagenomics market statistics, by country, 2018-2030 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more